{"studyId":"brca_mskcc_2019","cancerTypeId":"brca","name":"Breast Cancer (MSK, NPJ Breast Cancer 2019)","description":"Targeted Sequencing of buparlisib + letrozole and alpelisib + letrozole-treated metastatic ER+ unmatched breast tumors.","publicStudy":true,"pmid":"31552290","citation":"Nixon et al. NPJ Breast Cancer 2019","groups":"SOLITD;COMPONC;PUBLIC","status":1,"importDate":"2026-01-05 16:44:57","allSampleCount":70,"sequencedSampleCount":70,"cnaSampleCount":70,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":0,"structuralVariantCount":0,"cancerType":{"id":"brca","name":"Invasive Breast Carcinoma","dedicatedColor":"HotPink","shortName":"BRCA","parent":"breast"},"readPermission":true,"resourceCounts":[]}